Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
American Journal of Epidemiology
|
July 1, 1992
Aging and total cholesterol levels: cohort, period, and survivorship effects
C J Newschaffer, T L Bush, W E Hale
Journal of Gerontology
|
July 1, 1993
Medical conditions associated with driving cessation in community-dwelling, ambulatory elders
M K Campbell, T L Bush, W E Hale
Controlled Clinical Trials
|
August 1, 1995
The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Introduction
T L Bush, M A Espeland, I Mebane-Sims
Archives of Family Medicine
|
May 16, 2000
Racial differences in breast cancer mortality
J A Flaws, T L Bush, C J Newschaffer
Journal of Women'S Health
|
February 4, 1999
SERMs: the benefits of estrogen without the risks?
R C Cole, J A Flaws, T L Bush
Journal of Clinical Epidemiology
|
June 1, 1997
Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data
C J Newschaffer, T L Bush, L T Penberthy
Epidemiologic Reviews
|
January 1, 1991
Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease
A N Nafziger, D M Herrington, T L Bush
The New England Journal of Medicine
|
July 11, 1998
Effects of raloxifene in postmenopausal women
R C Cole, J A Flaws, T L Bush
Postgraduate Medicine
|
April 12, 2001
SERMs and cardiovascular disease in women. How do these agents affect risk?
T L Bush, R Blumenthal, R Lobo, et al.
Epidemiology (Cambridge, Mass.)
|
March 1, 1990
Body mass definitions of obesity: sensitivity and specificity using self-reported weight and height
F J Nieto-García, T L Bush, P M Keyl
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
American Journal of Epidemiology
|
July 1, 1992
Aging and total cholesterol levels: cohort, period, and survivorship effects
C J Newschaffer, T L Bush, W E Hale
Journal of Gerontology
|
July 1, 1993
Medical conditions associated with driving cessation in community-dwelling, ambulatory elders
M K Campbell, T L Bush, W E Hale
Controlled Clinical Trials
|
August 1, 1995
The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Introduction
T L Bush, M A Espeland, I Mebane-Sims
Archives of Family Medicine
|
May 16, 2000
Racial differences in breast cancer mortality
J A Flaws, T L Bush, C J Newschaffer
Journal of Women'S Health
|
February 4, 1999
SERMs: the benefits of estrogen without the risks?
R C Cole, J A Flaws, T L Bush
Journal of Clinical Epidemiology
|
June 1, 1997
Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data
C J Newschaffer, T L Bush, L T Penberthy
Epidemiologic Reviews
|
January 1, 1991
Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease
A N Nafziger, D M Herrington, T L Bush
The New England Journal of Medicine
|
July 11, 1998
Effects of raloxifene in postmenopausal women
R C Cole, J A Flaws, T L Bush
Postgraduate Medicine
|
April 12, 2001
SERMs and cardiovascular disease in women. How do these agents affect risk?
T L Bush, R Blumenthal, R Lobo, et al.
Epidemiology (Cambridge, Mass.)
|
March 1, 1990
Body mass definitions of obesity: sensitivity and specificity using self-reported weight and height
F J Nieto-García, T L Bush, P M Keyl
Page
of 10